Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of STERIS plc (NYSE:STE). In a filing disclosed on May 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in STERIS stock on April 29th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Revvity (NYSE:RVTY) on 5/1/2026.
- Sold $1,001 – $15,000 in shares of Flex (NASDAQ:FLEX) on 5/1/2026.
- Purchased $1,001 – $15,000 in shares of LPL Financial (NASDAQ:LPLA) on 5/1/2026.
- Purchased $1,001 – $15,000 in shares of FirstService (NASDAQ:FSV) on 5/1/2026.
- Sold $1,001 – $15,000 in shares of SS&C Technologies (NASDAQ:SSNC) on 5/1/2026.
- Purchased $1,001 – $15,000 in shares of Wayfair (NYSE:W) on 5/1/2026.
- Purchased $1,001 – $15,000 in shares of STERIS (NYSE:STE) on 5/1/2026.
- Purchased $1,001 – $15,000 in shares of DoorDash (NASDAQ:DASH) on 5/1/2026.
- Purchased $1,001 – $15,000 in shares of Sensata Technologies (NYSE:ST) on 5/1/2026.
- Purchased $1,001 – $15,000 in shares of Veralto (NYSE:VLTO) on 5/1/2026.
STERIS Stock Up 3.1%
NYSE STE traded up $6.23 during trading hours on Tuesday, hitting $208.08. 556,497 shares of the company were exchanged, compared to its average volume of 769,233. The company has a 50 day moving average of $222.37 and a two-hundred day moving average of $243.74. The company has a quick ratio of 1.75, a current ratio of 2.48 and a debt-to-equity ratio of 0.26. STERIS plc has a 52-week low of $195.14 and a 52-week high of $269.44. The firm has a market cap of $20.41 billion, a price-to-earnings ratio of 29.02 and a beta of 0.95.
STERIS Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 8th will be paid a dividend of $0.63 per share. This represents a $2.52 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Monday, June 8th. STERIS’s payout ratio is presently 35.15%.
Insider Activity at STERIS
In other news, Director Cynthia L. Feldmann sold 3,098 shares of the business’s stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $237.21, for a total value of $734,876.58. Following the completion of the sale, the director directly owned 705 shares of the company’s stock, valued at approximately $167,233.05. The trade was a 81.46% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.07% of the company’s stock.
Institutional Investors Weigh In On STERIS
Several institutional investors have recently added to or reduced their stakes in the business. Trust Co. of Vermont lifted its position in shares of STERIS by 30.2% during the 4th quarter. Trust Co. of Vermont now owns 164 shares of the medical equipment provider’s stock worth $42,000 after buying an additional 38 shares during the last quarter. Bailard Inc. lifted its position in STERIS by 3.5% in the fourth quarter. Bailard Inc. now owns 1,118 shares of the medical equipment provider’s stock valued at $283,000 after acquiring an additional 38 shares during the last quarter. Magnolia Capital Advisors LLC boosted its stake in STERIS by 1.2% in the third quarter. Magnolia Capital Advisors LLC now owns 3,588 shares of the medical equipment provider’s stock valued at $888,000 after acquiring an additional 41 shares in the last quarter. Colonial Trust Co SC boosted its stake in STERIS by 0.3% in the third quarter. Colonial Trust Co SC now owns 12,329 shares of the medical equipment provider’s stock valued at $3,051,000 after acquiring an additional 42 shares in the last quarter. Finally, Geneos Wealth Management Inc. grew its holdings in shares of STERIS by 34.9% during the second quarter. Geneos Wealth Management Inc. now owns 174 shares of the medical equipment provider’s stock worth $42,000 after purchasing an additional 45 shares during the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.
STERIS News Summary
Here are the key news stories impacting STERIS this week:
- Positive Sentiment: STERIS lifted FY2027 EPS guidance to $11.10-$11.30, above the consensus estimate, signaling confidence in future earnings growth. Reuters article
- Positive Sentiment: Revenue rose 7% year over year in fiscal Q4, showing the core medical equipment and sterilization business is still expanding. GlobeNewswire article
- Neutral Sentiment: Fourth-quarter EPS came in at $2.83 versus expectations of about $2.86, and revenue of $1.59 billion was slightly below estimates, a modest miss that tempers the upbeat outlook. Zacks article
- Neutral Sentiment: Management’s guidance for FY2027 revenue also came in roughly in line to slightly above expectations, reinforcing a steady but not dramatic growth profile. Yahoo Finance article
- Negative Sentiment: Recent insider activity has been mostly sales with no reported open-market purchases in the last six months, which may raise some caution among investors. Quiver Quantitative article
Analysts Set New Price Targets
A number of research analysts recently issued reports on STE shares. Wall Street Zen downgraded shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Sunday, April 26th. Weiss Ratings downgraded shares of STERIS from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Thursday, April 16th. Five analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $275.20.
View Our Latest Research Report on STE
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
STERIS Company Profile
STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.
Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.
Featured Stories
- Five stocks we like better than STERIS
- The DRAM Shake-Up: Samsung Stumbles, Micron Chases $1000
- MP Materials Is Quietly Building a Rare Earth Powerhouse
- AI Demand Fuels Strong Q1 Earnings for Constellation Energy
- Sony’s $4 Billion Bet on Rock & Roll Royalties
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.
